| Pharmaceutical active ingredients: |
| Sunitinib Malate |
| Available forms, composition and doses of Sutent 28: |
| Capsules; Oral; Sunitinib Malate 12.5 mgCapsules; Oral; Sunitinib Malate 25 mgCapsules; Oral; Sunitinib Malate 37.5 mgCapsules; Oral; Sunitinib Malate 50 mg |
| Sutent 28 medical category: |
| Human:Targeted cancer therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XE04 - Sunitinib |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerCPPI CVZuellig Pharma |
| Related documents and information about Sutent 28: |
| Sutent prescribing information (PDF) |